Literature DB >> 22010857

Activation of mTOR by human T-cell leukemia virus type 1 Tax is important for the transformation of mouse T cells to interleukin-2-independent growth.

Manami Yoshita1, Masaya Higuchi, Masahiko Takahashi, Masayasu Oie, Yuetsu Tanaka, Masahiro Fujii.   

Abstract

Human T-cell leukemia virus type 1 (HTLV-1) is a causative agent of adult T-cell leukemia, and it immortalizes and transforms human T cells in both an interleukin (IL)-2-dependent and -independent manner. HTLV-1 encodes Tax, which plays crucial roles in HTLV-1-mediated immortalization and transformation of human T cells. A previous study showed that Tax can transform a mouse T-cell line, CTLL-2, from having IL-2-dependent growth to IL-2-independent growth. Given that the Akt/mTOR pathway is essential for IL-2-induced cell growth in T cells, we examined whether the Akt/mTOR pathway is involved in Tax-induced transformation to IL-2-independent growth. The stable and transient expression of Tax in CTLL-2 induced the phosphorylation of p70S6 kinase and ribosomal protein S6, downstream targets of the mTOR kinase, whereas that of Akt was only minimally induced. Studies with Tax mutants indicated that the activation of mTOR by Tax was correlated with the transformation of CTLL-2 cells to IL-2-independent growth. Rapamycin, an inhibitor of mTOR kinase, reduced the growth of Tax-transformed CTLL-2 cells. Moreover, the transduction of a constitutively active form of Akt in the CTLL-2 cells also induced IL-2-independent growth. Like CTLL-2/Tax, constitutive phosphorylation of p70S6 kinase was detected in the absence of IL-2 in all of the HTLV-1-infected human T-cell lines. These results suggest that Tax activates the mTOR pathway in T cells, and that this activation plays a crucial role in the growth of HTLV-1-infected T cells when a limited amount of IL-2 is available.
© 2011 Japanese Cancer Association.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22010857     DOI: 10.1111/j.1349-7006.2011.02123.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  8 in total

1.  MAGI-1 expression is decreased in several types of human T-cell leukemia cell lines, including adult T-cell leukemia.

Authors:  Takashi Kozakai; Masahiko Takahashi; Masaya Higuchi; Toshifumi Hara; Kousuke Saito; Yuetsu Tanaka; Masayoshi Masuko; Jun Takizawa; Hirohito Sone; Masahiro Fujii
Journal:  Int J Hematol       Date:  2017-10-17       Impact factor: 2.490

2.  Human T-cell leukemia virus type 1 Tax oncoprotein represses the expression of the BCL11B tumor suppressor in T-cells.

Authors:  Takayuki Takachi; Masahiko Takahashi; Manami Takahashi-Yoshita; Masaya Higuchi; Miki Obata; Yukio Mishima; Shujiro Okuda; Yuetsu Tanaka; Masao Matsuoka; Akihiko Saitoh; Patrick L Green; Masahiro Fujii
Journal:  Cancer Sci       Date:  2015-03-16       Impact factor: 6.716

3.  Modulation of autophagy-like processes by tumor viruses.

Authors:  Hildegard I D Mack; Karl Munger
Journal:  Cells       Date:  2012-06-25       Impact factor: 6.600

Review 4.  Regulation of HTLV-1 transformation.

Authors:  Kyle J Ernzen; Amanda R Panfil
Journal:  Biosci Rep       Date:  2022-03-31       Impact factor: 3.840

Review 5.  MiR-150 in HTLV-1 infection and T-cell transformation.

Authors:  Donna M D'Agostino; Vittoria Raimondi; Micol Silic-Benussi; Vincenzo Ciminale
Journal:  Front Immunol       Date:  2022-08-16       Impact factor: 8.786

6.  HTLV tax: a fascinating multifunctional co-regulator of viral and cellular pathways.

Authors:  Robert Currer; Rachel Van Duyne; Elizabeth Jaworski; Irene Guendel; Gavin Sampey; Ravi Das; Aarthi Narayanan; Fatah Kashanchi
Journal:  Front Microbiol       Date:  2012-11-30       Impact factor: 5.640

7.  Downregulation of proapoptotic Bim augments IL-2-independent T-cell transformation by human T-cell leukemia virus type-1 Tax.

Authors:  Masaya Higuchi; Masahiko Takahashi; Yuetsu Tanaka; Masahiro Fujii
Journal:  Cancer Med       Date:  2014-08-30       Impact factor: 4.452

8.  Dual inhibition of the mTORC1 and mTORC2 signaling pathways is a promising therapeutic target for adult T-cell leukemia.

Authors:  Takahito Kawata; Kohei Tada; Masayuki Kobayashi; Takashi Sakamoto; Yoko Takiuchi; Fumie Iwai; Maki Sakurada; Masakatsu Hishizawa; Kotaro Shirakawa; Keisuke Shindo; Hironori Sato; Akifumi Takaori-Kondo
Journal:  Cancer Sci       Date:  2017-11-22       Impact factor: 6.716

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.